{"id":"W2170476788","doi":"10.1158/1078-0432.ccr-10-0939","title":"Poly(ADP-Ribose) Polymerase Inhibition: “Targeted” Therapy for Triple-Negative Breast Cancer","year":2010,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Breast cancer; Triple-negative breast cancer; PARP inhibitor; Cancer research; Poly ADP ribose polymerase; Cancer; Synthetic lethality; Medicine; DNA repair; Targeted therapy; Polymerase; Biology; Internal medicine; DNA; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.005380233,0.001104723,0.004657219,0.000905507,0.0008017999,0.0002254679,0.0007963139,0.002286167,0.009146569],"category_scores_gemma":[0.001077327,0.0008533163,0.002656369,0.002100595,0.002636292,0.0002318814,0.0002309934,0.007457322,0.0002954878],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001512105,"about_ca_system_score_gemma":0.01449188,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001269641,"about_ca_topic_score_gemma":0.0002670619,"domain_scores_codex":[0.9890253,0.001776064,0.002941704,0.002289617,0.002065104,0.001902222],"domain_scores_gemma":[0.9881929,0.005242765,0.0009689691,0.001810797,0.002389977,0.001394635],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003167506,0.0007321629,0.00008932367,0.004765425,0.0008361611,0.00005875981,0.00007969396,4.921962e-8,0.00002980115,0.0001062755,0.07548891,0.9146459],"study_design_scores_gemma":[0.009848897,0.001098999,0.0001712498,0.01736051,0.0004900079,0.0001190739,0.00003274782,0.000005069485,0.0004230257,0.0004315023,0.9691887,0.0008302039],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001262456,0.9688742,0.00004055159,0.009553727,0.00402899,0.008642315,0.007859602,0.0001939019,0.0006805388],"genre_scores_gemma":[0.00008493994,0.9511156,0.0003038234,0.002224784,0.02184813,0.01687607,0.0005973419,0.0004219305,0.00652737],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9138157,"threshold_uncertainty_score":0.9993917,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4045928384629675,"score_gpt":0.609833792293307,"score_spread":0.2052409538303395,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}